Skip to main content
Case Reports in Dermatology logoLink to Case Reports in Dermatology
. 2016 Feb 24;8(1):52–58. doi: 10.1159/000444317

Merkel Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study

Hitoshi Terui a,b, Taku Fujimura a,*, Aya Kakizaki a, Sadanori Furudate a, Setsuya Aiba a
PMCID: PMC4899652  PMID: 27293394

Abstract

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma that only rarely regresses spontaneously. Since little is known about the immunological mechanisms involved in the spontaneous regression of MCC, we describe a case of MCC with spontaneous regression and employed immunohistochemical staining for cytotoxic and immunosuppressive molecules to investigate possible mechanisms involved in the spontaneous regression of MCC. Interestingly, compared to conventional MCC, tumor-infiltrating lymphocytes in MCC with spontaneous regression contained higher numbers of CD8+ cells and granulysin-bearing cells and lower numbers of CD206+ cells. Our present study suggests one of the possible reasons for the spontaneous regression of MCC.

Key Words: Merkel cell carcinoma, Spontaneous regression, Granulysin, Tumor-associated macrophages

Introduction

Merkel cell carcinoma (MCC) is an aggressive, cutaneous, neuroendocrine carcinoma that originates from either Merkel cells or from pluripotent stem cells in the basal layer of the epidermis [1, 2]. MCC can spontaneously regress [3, 4, 5], although such cases are extremely rare. Recent reports suggested that the type of tumor-infiltrating leukocytes (TILs) could determine the prognosis and tumor-specific survival of MCC [6, 7, 8]. Therefore, in this report, we employed immunohistochemical staining for cytotoxic and immunosuppressive molecules to investigate the possible mechanisms involved in the spontaneous regression of MCC.

Case Presentation

A 94-year-old Japanese woman visited our outpatient clinic with a 2-month history of a tumor on her left cheek. On her initial visit, physical examination revealed a red-colored, elastic, soft, well-demarcated nodule on her left cheek (fig. 1a). The size of the tumor was of approximately 22 × 20 mm in diameter. A biopsy specimen from her cheek revealed sheets of small cells with hyperchromatic nuclei extending throughout the dermis with prominent leukocytes (fig. 2a). Immunohistochemical staining revealed that these atypical cells were positive for CK20, synaptophysin (fig. 2b) and neuron-specific enolase, and negative for chromogranin A, thyroid transcription factor 1, S-100, Melan-A and HMB-45. From the above findings, we diagnosed this case as MCC. Surprisingly, the tumor spontaneously regressed 20 days after the biopsy (fig. 1b).

Fig. 1.

Fig. 1

a A red-colored, elastic, soft, well-demarcated nodule on the left cheek. b The tumor spontaneously regressed 20 days after the biopsy.

Fig. 2.

Fig. 2

a Sheets of small cells with hyperchromatic nuclei extending throughout the dermis with prominent leukocytes. b Paraffin-embedded tissue samples were deparaffinized and stained with anti-synaptophysin antibodies. The sections were developed with 3,3′-diaminobenzidine tetrahydrochloride (original magnification ×100).

To further investigate the possible mechanisms in the spontaneous regression, we employed immunohistochemical staining of CD8 (fig. 3a), CD163, CD206, Foxp3, granulysin (fig. 3b) and caspase 3 (fig. 3c) for the present case and 5 cases of conventional MCC. We counted the number of immunoreactive cells, using an ocular grid of 1 cm2 at a magnification of ×400. In the present case, the number of CD8+ cells, granulysin-bearing cells and caspase 3+ cells tended to be higher than in conventional MCC cases (fig. 4). In contrast, the number of CD206+ cells tended to be lower than in conventional MCC cases. There was no difference in the number of CD163+ and Foxp3+ cells between these groups.

Fig. 3.

Fig. 3

Paraffin-embedded tissue samples were deparaffinized and stained with anti-CD8 antibodies (a), anti-granulysin antibodies (b), and anti-caspase 3 antibodies (c). The sections were developed with Liquid Permanent Red (original magnification ×100).

Fig. 4.

Fig. 4

Summary of the average number of immunoreactive cells in the 5 conventional MCC cases and the present case. Three representative fields of each section were selected from tumor areas with dense dermal lymphoid infiltrates. The number of immunoreactive cells was counted using an ocular grid of 1 cm2 at a magnification of ×400. The data are expressed as the means ± SD of the numbers in each area. White bars: conventional MCC; black bars: present case.

Discussion

Previous reports suggested the importance of evaluating the tumor microenvironment in the lesional skin of MCC. Indeed, Paulson et al. [6] reported an association between the infiltration of intratumoral CD8+ lymphocytes and improved MCC-specific survival. Notably, CD8+ cells contain various subpopulations of cytotoxic T cells, including granulysin-bearing cells. Granulysin has homology to other cytotoxic molecules of the saponin-like protein family [9] and lyses various tumors, which might be related to the prognosis of cancer patients and the self-regression of tumors [10, 11, 12, 13].

In the present case, compared to the 5 cases of conventional MCC, the numbers of CD8+ cells, granulysin-bearing cells and caspase 3+ cells were higher. In addition, a recent report also suggested the significance of the expression of PD-1 on TILs [3]. These observations suggested that the anti-tumor immune reaction in MCC might mainly correlate with cytotoxic T cells.

Concerning tumor-associated macrophages (TAMs), in contrast to cytotoxic T cells, there was no difference in the numbers of immunosuppressive cells (CD163+ TAMs and Foxp3+ regulatory T cells) between MCC with or without spontaneous regression. Since there was no difference of the numbers of CD163+ cells in each group, to assess the expression of M2 markers, such as CD206, on TAMs is important [14, 15]. Indeed, the number of CD206+ cells, which could be one of the markers for M2 macrophages, was lower in MCC with spontaneous regression. Notably, M2-polarized TAMs produce various chemokines that recruit TILs to maintain the immunosuppressive tumor microenvironment [16, 17]. In aggregate, a lower number of CD206+ TAMs might correlate with the increased number of cytotoxic T cells in the present case.

In this report, we described a case of MCC with spontaneous regression and employed immunohistochemical staining for cytotoxic and immunosuppressive molecules to investigate the possible mechanisms in the spontaneous regression of MCC. Since this report presents a single case of MCC with spontaneous regression, further analysis of the mechanisms underlying this phenomenon may provide fundamental insights into the mechanisms of cytotoxic T cells and TAMs in the spontaneous regression of MCC. Such issues will need to be clarified in future investigations.

Statement of Ethics

The patient gave written informed consent.

Disclosure Statement

The authors declare no conflicts of interest.

References

  • 1.Ferringer T, Rogers HC, Metcalf JS. Merkel cell carcinoma in situ. J Cutan Pathol. 2005;32:162–165. doi: 10.1111/j.0303-6987.2005.00270.x. [DOI] [PubMed] [Google Scholar]
  • 2.Van Keymeulen A, Mascre G, Youseff KK, Harel I, Michaux C, De Geest N, Szpalski C, Achouri Y, Bloch W, Hassan BA, Blanpain C. Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol. 2009;187:91–100. doi: 10.1083/jcb.200907080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fujimoto N, Nakanishi G, Kabuto M, Nakano T, Eto H, Nakajima H, Sano S, Tanaka T. Merkel cell carcinoma showing regression after biopsy: evaluation of programmed cell death 1-positive cells. J Dermatol. 2015;42:496–499. doi: 10.1111/1346-8138.12805. [DOI] [PubMed] [Google Scholar]
  • 4.Kayashima K, Ono T, Johno M, Kojo Y, Yamashita N, Matsunaga W. Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch Dermatol. 1991;127:550–553. [PubMed] [Google Scholar]
  • 5.Duncan WC, Tschen JA. Spontaneous regression of Merkel cell (neuroendocrine) carcinoma of the skin. J Am Acad Dermatol. 1993;29:653–654. doi: 10.1016/s0190-9622(08)81877-4. [DOI] [PubMed] [Google Scholar]
  • 6.Paulson KG, Iyer JG, Tegeder AR, et al. Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol. 2011;29:1539–1546. doi: 10.1200/JCO.2010.30.6308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dowlatshahi M, Huang V, Gehad AE, et al. Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol. 2013;133:1879–1889. doi: 10.1038/jid.2013.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Asgari MM, Sokil MM, Warton EM, et al. Effect of host tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol. 2014;150:716–723. doi: 10.1001/jamadermatol.2013.8116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Krensky AM, Clayberger C. Granulysin: a novel host defense molecule. Am J Transplant. 2005;5:1789–1792. doi: 10.1111/j.1600-6143.2005.00970.x. [DOI] [PubMed] [Google Scholar]
  • 10.Pagés F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J. Effector memory T cells early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654–2666. doi: 10.1056/NEJMoa051424. [DOI] [PubMed] [Google Scholar]
  • 11.Kambayashi Y, Fujimura T, Furudate S, Hashimoto A, Haga T, Aiba S. Comparison of immunosuppressive cells and cytotoxic cells in angiosarcoma: the development of a possible supportive therapy for angiosarcoma. Dermatology. 2013;227:14–20. doi: 10.1159/000351316. [DOI] [PubMed] [Google Scholar]
  • 12.Furudate S, Fujimura T, Kambayashi Y, Kawano M, Ogasawara K, Tsukada A, Tamabuchi E, Haga T, Hashimoto A, Aiba S. Successful treatment of adult onset Langerhans cell histiocytosis with bi-weekly administration of pegylated interferon-α. Acta Derm Venereol. 2014;94:611–612. doi: 10.2340/00015555-1807. [DOI] [PubMed] [Google Scholar]
  • 13.Furudate S, Fujimura T, Tsukada A, Numata Y, Kambayashi Y, Aiba S. Profiles of tumor-infiltrating lymphocytes in a case of trichilemmal carcinoma with spontaneous regression. Case Rep Dermatol. 2012;4:215–221. doi: 10.1159/000343881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kambayashi Y, Fujimura T, Furudate S, Asano M, Kakizaki A, Aiba S. The possible interaction between receptor activator of nuclear factor kappa-B ligand (RANKL) expressed by extramammary Paget cells and its ligand on dermal macrophages. J Invest Dermatol. 2015;135:2547–2550. doi: 10.1038/jid.2015.199. [DOI] [PubMed] [Google Scholar]
  • 15.Kakizaki A, Fujimura T, Kambayashi Y, Furudate S, Kawano M, Ogasawara K, Aiba S. Comparison of CD163+ macrophages and CD206+ cells in lesional skin of CD30+ lymphoproliferative disorders of lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Acta Derm Venereol. 2015;95:600–602. doi: 10.2340/00015555-2016. [DOI] [PubMed] [Google Scholar]
  • 16.Fujimura T, Kambayashi Y, Furudate S, Asano M, Kakizaki A, Aiba S. Receptor activator of nuclear factor kappa-B ligand (RANKL) promotes the production of CCL17 from RANK+ M2 macrophages. J Invest Dermatol. 2015;135:2884–2887. doi: 10.1038/jid.2015.209. [DOI] [PubMed] [Google Scholar]
  • 17.Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Aiba S. Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma. Clin Dev Immunol 2013. 2013 doi: 10.1155/2013/325412. 325412. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Case Reports in Dermatology are provided here courtesy of Karger Publishers

RESOURCES